Interstitial lung disease in the newborn
Interstitial lung disease in the newborn

Interstitial lung disease in the newborn

J Perinatol. 2024 Jul 2. doi: 10.1038/s41372-024-02036-9. Online ahead of print.

ABSTRACT

Although relatively rare, interstitial lung diseases may present with respiratory distress in the newborn period. Most commonly these include developmental and growth disorders, disorders of surfactant synthesis and homeostasis, pulmonary interstitial glycogenosis, and neuroendocrine cell hyperplasia of infancy. Although the diagnosis of these disorders is sometimes made based on clinical presentation and imaging, due to the significant overlap between disorders and phenotypic variability, lung biopsy or, increasingly genetic testing is needed for diagnosis. These diseases may result in significant morbidity and mortality. Effective medical treatment options are in some cases limited and/or invasive. The genetic basis for some of these disorders has been identified, and with increased utilization of exome and whole genome sequencing even before lung biopsy, further insights into their genetic etiologies should become available.

PMID:38956315 | DOI:10.1038/s41372-024-02036-9